1.91
Schlusskurs vom Vortag:
$1.95
Offen:
$1.97
24-Stunden-Volumen:
1.84M
Relative Volume:
0.24
Marktkapitalisierung:
$113.65M
Einnahmen:
$45.91M
Nettoeinkommen (Verlust:
$-4.62M
KGV:
-13.62
EPS:
-0.1402
Netto-Cashflow:
$-21.51M
1W Leistung:
+67.54%
1M Leistung:
+374.30%
6M Leistung:
+150.20%
1J Leistung:
+83.65%
Equillium Inc Stock (EQ) Company Profile
Firmenname
Equillium Inc
Sektor
Branche
Telefon
(858) 412-5302
Adresse
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Vergleichen Sie EQ mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
EQ
Equillium Inc
|
1.91 | 69.65M | 45.91M | -4.62M | -21.51M | -0.1402 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-28 | Herabstufung | Leerink Partners | Outperform → Market Perform |
2021-10-29 | Fortgesetzt | Stifel | Buy |
2021-09-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-07-14 | Bestätigt | H.C. Wainwright | Buy |
2020-07-10 | Fortgesetzt | Stifel | Buy |
2019-02-22 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Equillium Inc Aktie (EQ) Neueste Nachrichten
Momentum divergence signals in Equillium Inc. chart2025 Winners & Losers & Technical Entry and Exit Tips - Newser
Developing predictive dashboards with Equillium Inc. dataWeekly Stock Report & Low Risk High Win Rate Stock Picks - Newser
Equillium Inc. stock trend forecastSwing Trade & Community Consensus Picks - Newser
Can machine learning forecast Equillium Inc. recoveryPortfolio Update Report & Growth Oriented Trade Recommendations - Newser
Live Scanner Shows Breakout on Equillium Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Why Equillium Inc. is moving today2025 Performance Recap & AI Driven Stock Reports - Newser
How to interpret RSI for Equillium Inc. stockMarket Movement Recap & Free Technical Pattern Based Buy Signals - Newser
Ranking Equillium Inc. among high performing stocks via toolsInsider Selling & Weekly Watchlist for Consistent Profits - Newser
Has Equillium Inc. formed a bullish divergence2025 Fundamental Recap & Weekly High Momentum Picks - Newser
Equillium Inc. Hits Oversold Level on RSI IndicatorJuly 2025 Market Mood & Weekly Top Gainers Alerts - classian.co.kr
How to integrate Equillium Inc. into portfolio analysis toolsJuly 2025 Market Mood & High Accuracy Trade Signal Alerts - Newser
Why Equillium Inc. stock attracts strong analyst attentionEarnings Miss & Smart Swing Trading Techniques - kpenews.com
Is Equillium Inc. a defensive stock2025 Stock Rankings & Consistent Profit Focused Trading Strategies - theviewers.co.kr
Combining price and volume data for Equillium Inc.July 2025 Catalysts & Growth Focused Entry Point Reports - Newser
Historical volatility pattern of Equillium Inc. visualizedWeekly Trade Summary & Real-Time Sentiment Analysis - Newser
Quant Funds Rotate Into Equillium Inc. StockJuly 2025 Intraday Action & High Win Rate Trade Tips - 더경남뉴스
Aug Breakouts: What is the dividend yield of Equillium Inc.Weekly Gains Summary & Intraday High Probability Setup Alerts - baoquankhu1.vn
Equillium Soars 29% on Biotech Breakthrough Hype: Is This a Short-Lived Rally or a New Trend? - AInvest
Is Equillium Inc. stock entering bullish territory2025 Key Lessons & Daily Technical Forecast Reports - Newser
Options Data Show Bullish Bias in Equillium Inc.2025 Technical Patterns & Free Community Supported Trade Ideas - Newser
Equillium Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Will Equillium Inc. stock go up soonEarnings Trend Report & Stepwise Entry and Exit Trade Signals - Newser
Equillium (EQ) up more than 200% since Jul 24 - AInvest
Custom watchlist performance reports with Equillium Inc.Earnings Risk Summary & Weekly Watchlist for Consistent Profits - Newser
Equillium Shares Drop 12.4% After Unveiling Cryptocurrency Treasury Strategy - MSN
Can Equillium Inc. outperform in the next rallyQuarterly Earnings Summary & Daily Profit Focused Stock Screening - thegnnews.com
Unusual Intraday Move in Equillium (EQ.O) – What’s Behind the 16% Swing? - AInvest
Will breakout in Equillium Inc. lead to full recoveryJuly 2025 Decliners & Daily Entry Point Alerts - Newser
Should you hold or exit Equillium Inc. nowQuarterly Trade Review & Stock Market Timing Techniques - Newser
Will Equillium Inc. benefit from green energy policiesWeekly Market Summary & Real-Time Volume Analysis Alerts - thegnnews.com
What machine learning models say about Equillium Inc.Recession Risk & AI Forecast Swing Trade Picks - Newser
Tools to monitor Equillium Inc. recovery probabilityJuly 2025 WrapUp & AI Enhanced Trading Alerts - Newser
Equillium Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Equillium 2024 Q4 Earnings Wider Losses Despite Record High Net Income - AInvest
Equillium (EQ) Surges 22.44% Intraday: What's Fueling This Biotech Breakout? - AInvest
Equillium (EQ) Surges 21.9% Intraday: What's Fueling This Biotech Rally? - AInvest
Unraveling the Sudden 20% Surge in Equillium (EQ.O) Despite Lack of Fundamental Catalyst - AInvest
Equillium 2024 Q4 Earnings Widening Losses Despite Record Net Loss - AInvest
Equillium's Financial Strategy and Clinical Trial Uncertainties: A Hold Rating - AInvest
Will Equillium Inc. Sustain Its Chart BreakoutMarket Risk Summary & Weekly Consistent Profit Watchlists - newsimpact.co.kr
Mintz Advises on Equillium, Inc.'s up to $50 Million PIPE - Mintz
Finanzdaten der Equillium Inc-Aktie (EQ)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):